Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
26 Oktober 2023
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS)
3 Februar 2022
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
4 Februar 2021
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2020 (IFRS)
29 Oktober 2020
24 August 2020
Takeda Pharmaceutical Company Limited: Takeda to Divest its Japan Consumer Health Care Business Unit to Blackstone for JPY 242.0 Billion
31 Juli 2020
4 Februar 2020
Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)
31 Oktober 2019
6 September 2019
Takeda Pharmaceutical Company Limited: Takeda Issues US Recall of NATPARA(R) (parathyroid hormone) for Injection Due to the Potential for Rubber Particulate
31 Juli 2019
Takeda Pharmaceutical Company Limited: Takeda Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year
25 April 2019
Takeda Pharmaceutical Company Limited: Revised Forecast of Consolidated Financials for FY2018 (IFRS)
